Van Hoose Kyri K. 4
4 · Dermata Therapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Van Hoose Kyri K.
SVP, CFO
Transactions
- Award
Stock Option (right to buy)
2023-01-03+100,000→ 100,000 totalExercise: $0.31Exp: 2033-01-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.